Produits
Produits en développement
Corticoïdes & Hormones
| Produits | Stade de développement | ATC 4 CLASS |
| Abiraterone Acetate (customized particle engineering) | R&D | L2B2 : CYTOSTATIC ANTI-ANDROGENS |
| Estradiol | Echantillons | QG03CA03: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM NATURAL AND SEMI SYNTHETIC ESTROGENS, PLAIN |
| Estradiol hemihydrate | Echantillons | G3C : OESTROGENS, EXCLUDING G3A, G3E, G3F G3F OESTROGEN WITH PROGESTOGEN COMBINATIONS, EXCLUDING G3A |
| Estradiol Valerate | R&D | G3A HORMONAL CONTRACEPTIVES, SYSTEMIC G3F OESTROGEN WITH PROGESTOGEN COMBINATIONS, EXCLUDING G3A |
| Ethinylestradiol | R&D | G3A HORMONAL CONTRACEPTIVES, SYSTEMIC D10B ORAL ANTI-ACNE PREPARATIONS |
| Fluticasone Furoate | R&D | R3F1 B2-AGONIST AND CORTICOID COMBINATIONS, INHALANT R1A TOPICAL NASAL PREPARATIONS |
Prostaglandines
| Produits | Stade de développement | ATC 4 CLASS |
| Lubiprostone | Développement | A6A9 OTHER DRUGS FOR CONSTIPATION A3G GASTRO-INTESTINAL SENSORIMOTOR MODULATORS |
| Misoprostol | R&D | G3X : OTHER SEX HORMONES AND SIMILAR PRODUCTS / A2B3 PROSTAGLANDIN ANTIULCERANTS |
| Misoprostol HPMC dispersion | R&D | G3X : OTHER SEX HORMONES AND SIMILAR PRODUCTS / A2B3 PROSTAGLANDIN ANTIULCERANTS |
Opiacés et substances contrôlées
| Produits | Stade de développement | ATC 4 CLASS |
| Buprenorphine base | Développement | N7F DRUGS USED IN OPIOID DEPENDENCE N2A NARCOTIC ANALGESICS |
| Buprenorphine Hydrochloride | Développement | N7F DRUGS USED IN OPIOID DEPENDENCE N2A NARCOTIC ANALGESICS |
Molécules petites et complexes
| Produits | Stade de développement | ATC 4 CLASS |
| Adrenaline (Epinephrine) base | R&D | C1C1 : CARDIAC STIMULANTS EXCLUDING DOPAMINERGIC AGENTS R3X1 : ALL OTHER ANTI-ASTHMA AND COPD PRODUCTS, INHALANT / N1B1 ANAESTHETICS LOCAL, MEDICAL INJECTABLES D3A9 ALL OTHER WOUND HEALING AGENTS |
| Adrenaline (Epinephrine) bitartrate | R&D | C1C1 : CARDIAC STIMULANTS EXCLUDING DOPAMINERGIC AGENTS N1B1 ANAESTHETICS LOCAL, MEDICAL INJECTABLES |
| Adrenaline (Epinephrine) hydrochloride | R&D | C1C1 : CARDIAC STIMULANTS EXCLUDING DOPAMINERGIC AGENTS R3X1 : ALL OTHER ANTI-ASTHMA AND COPD PRODUCTS, INHALANT / N1B1 ANAESTHETICS LOCAL, MEDICAL INJECTABLES D3A9 ALL OTHER WOUND HEALING AGENTS |
Anti-infectieux
| Produits | Stade de développement | ATC 4 CLASS |
| Daptomycin | Développement | J1X9 ALL OTHER ANTIBACTERIALS |
| Fidaxomicin | R&D | A7A INTESTINAL ANTI-INFECTIVES |
| Tulathromycin | R&D | VETERINARY USE ONLY - QJ01FA MACROLIDES* |
Autre plateforme produits
| Plateforme | Produit | Stade de développement | ATC 4 CLASS |
| Oligonucleotides & Peptides | Inclisiran | R&D | C10A9 ALL OTHER CHOLESTEROL/TRIGLYCERIDE REGULATORS |